669055-52-1

669055-52-1 structure

Name: N6,N6-Dimethyl-xylo-adenosine
Chemical Name: 9-(β-D-xylofuranosyl)-N6,N6-dimethyladenine
CAS Number: 669055-52-1
Molecular Formula: C₁₂H₁₇N₅O₄
Molecular Weight: 295.29
Catalog: Signaling Pathways Cell Cycle/DNA Damage Nucleoside Antimetabolite/Analog
Create Date: 2016-03-08 16:50:52
Modify Date: 2024-04-04 16:45:53
N6,N6-Dimethyl-xylo-adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].

Name	9-(β-D-xylofuranosyl)-N6,N6-dimethyladenine
Synonyms	(1R)-1-(6-dimethylamino-purin-9-yl)-D-1,4-anhydro-xylitol (1R)-1-(6-Dimethylamino-purin-9-yl)-D-1,4-anhydro-xylit

Description	N6,N6-Dimethyl-xylo-adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog
References	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. [2]. Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500.

Precursor 0
DownStream 1
58-60-6